HPS Pharmacies wishes to give notice that Pfizer is making some changes to the support provided by the Clopine® Services Team. The following changes will come into effect on 1 February 2024:

  • The role of the Clopine® Services Team will be limited to directing users to the haematologist and will no longer be a conduit of information between the haematologist and the user.
  • Additional blood or medical history files will not be handled by the Clopine® Services Team and must be discussed with the haematologist directly.
  • Any adjustments to monitoring (e.g. overrides) must be entered directly into ClopineCENTRAL® by the treating team.
  • Users are strongly encouraged to record and maintain all patient medical history (including information from the haematology consultations) in their own internal records.

Pfizer advises that these changes are being made with the intention of streamlining their services. They are not related to any safety, efficacy or quality issues with the service.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact the Clopine® Services Team on 1800 656 403, or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates